Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
163.32%
operating margin TTM
-42.86%
revenue TTM
42.33 Million
revenue per share TTM
5.6$
valuation ratios | |
|---|---|
| pe ratio | 0.78 |
| peg ratio | 0.00 |
| price to book ratio | 0.49 |
| price to sales ratio | 1.24 |
| enterprise value multiple | 1.35 |
| price fair value | 0.49 |
profitability ratios | |
|---|---|
| gross profit margin | 62.53% |
| operating profit margin | -42.86% |
| pretax profit margin | 213.0% |
| net profit margin | 163.32% |
| return on assets | 35.31% |
| return on equity | 103.52% |
| return on capital employed | -11.52% |
liquidity ratios | |
|---|---|
| current ratio | 3.96 |
| quick ratio | 3.83 |
| cash ratio | 3.17 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 116.06 |
| operating cycle | 311.98 |
| days of payables outstanding | 168.70 |
| cash conversion cycle | 143.28 |
| receivables turnover | 1.86 |
| payables turnover | 2.16 |
| inventory turnover | 3.15 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.20 |
| debt equity ratio | 0.39 |
| long term debt to capitalization | 0.22 |
| total debt to capitalization | 0.28 |
| interest coverage | -3.27 |
| cash flow to debt ratio | 1.94 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.97 |
| cash per share | 6.21 |
| operating cash flow per share | 3.98 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 1.94 |
| short term coverage ratios | 17.38 |
| capital expenditure coverage ratio | 1,593.92 |
Frequently Asked Questions
When was the last time Fortress Biotech, Inc. (NASDAQ:FBIOP) reported earnings?
Fortress Biotech, Inc. (FBIOP) published its most recent earnings results on 13-08-2026.
What is Fortress Biotech, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Fortress Biotech, Inc. (NASDAQ:FBIOP)'s trailing twelve months ROE is 103.52%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Fortress Biotech, Inc. (FBIOP) currently has a ROA of 35.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did FBIOP's net profit margin stand at?
FBIOP reported a profit margin of 163.32% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is FBIOP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.96 in the most recent quarter. The quick ratio stood at 3.83, with a Debt/Eq ratio of 0.39.